Publication | Closed Access

Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial

Metabolic SyndromeLipid DisorderHomozygous Familial HypercholesterolaemiaOxysterolMedicineImmunologyPathologyTesla Part BPlacebo-controlled TrialHyperlipidemiaPharmacologyAtherosclerosisDyslipidemiaOxidative Stress